NEW YORK, NY – As October arrives, the discourse surrounding Breast Cancer Awareness Month often focuses on the success stories of early detection and the completion of treatment. However, for a specific, vulnerable population, the conversation remains vastly different. On October 13, National Metastatic Breast Cancer (MBC) Awareness Day, the nonprofit organization METAvivor Research and Support will once again bridge the gap between public awareness and scientific reality with its global campaign, #LightUpMBC.
More than 325 landmarks across all 50 U.S. states, 20 countries, and 195 cities will illuminate in the signature colors of MBC—teal, green, and pink. This synchronized display serves as a poignant tribute to lives lost, a gesture of solidarity for those currently navigating the disease, and a vital engine for raising the funds necessary to transform terminal breast cancer into a survivable condition.
The Reality of Stage 4: More Than Just a Diagnosis
Metastatic breast cancer, also classified as Stage 4, occurs when cancer cells spread from the original site in the breast to distant organs, most commonly the bones, liver, lungs, or brain. It is crucial to understand that even when the cancer spreads, it remains breast cancer, named and treated based on its origin.
For many, the diagnosis is a shock; some patients are classified as Stage 4 from their initial consultation, while others experience a recurrence months, years, or even decades after completing treatment for earlier-stage disease. Unlike localized cancer, MBC is currently considered incurable. Treatment is a lifelong, ongoing commitment, often involving a rotating regimen of therapies designed to control the disease, extend life, and preserve quality of life. As the disease progresses, cancer cells often develop resistance to treatments, forcing patients into a constant, exhausting cycle of trial and error.
The scale of the crisis is immense. In the United States alone, an estimated 42,670 people are expected to lose their lives to breast cancer in 2026—a harrowing statistic that equates to approximately 117 deaths every single day. These are not merely numbers; they represent friends, parents, partners, and colleagues whose lives are being cut short by a disease that receives only a fraction of the research funding dedicated to early-stage cancer.
Chronology of a Movement: From a Single Light to a Global Beacon
The #LightUpMBC campaign traces its roots to a deeply personal origin story. It was conceived by Laura Inahara, who sought to honor the memory of her best friend, Jessica Moore. Moore, who was diagnosed with metastatic breast cancer at the age of 36, harbored a simple, heartfelt wish: to see one local landmark illuminated to raise awareness for the disease that was claiming her life.
Following Moore’s passing, Inahara turned that singular wish into a global movement. In 2017, the campaign achieved its first milestone when the Memorial Bridge in Portsmouth, New Hampshire, became the first landmark to light up in the MBC colors.
Over the subsequent nine years, the initiative expanded exponentially. What began as a local tribute has evolved into a worldwide phenomenon, uniting disparate cities—from the bustling streets of New York City, where the One World Trade Center will shine, to the iconic Willis Tower in Chicago, the mist-covered falls of Niagara, and the Ness Bridge in Inverness, Scotland. The campaign has now raised over $2.7 million, proving that a singular, grief-stricken wish can catalyze a massive, life-saving shift in how the medical community and the public address Stage 4 cancer.
Supporting Data: Why Research is the Only Way Forward
METAvivor remains the only national organization in the United States that exclusively funds Stage 4 metastatic breast cancer research. Unlike organizations that distribute funds across the broad spectrum of breast cancer care, METAvivor focuses its entire financial weight on the stage of the disease that kills.
The organization employs a rigorous scientific peer and patient advocate review process to select its research projects. By involving patients in the grant-reviewing process, METAvivor ensures that the research funded is not only scientifically sound but also clinically relevant to the needs of those living with the disease.
The financial stakes are clear. According to the National Cancer Institute (NCI) and the Surveillance, Epidemiology, and End Results (SEER) Program, while survival rates for early-stage breast cancer have seen massive improvements, the five-year survival rate for Stage 4 breast cancer remains significantly lower. Research into drug resistance, metastatic pathways, and systemic therapy is the only viable path to turning this terminal diagnosis into a chronic, manageable, and ultimately survivable condition.
Official Responses: The Human Faces of the Fight
The leadership at METAvivor is comprised of individuals who understand the stakes with unparalleled clarity. Dr. Kelly Shanahan, Board President of METAvivor, has been living with metastatic breast cancer since 2013. Her survival—now stretching into its 13th year—is a testament to the power of medical advancement.
"When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan remarked. "My hope and the hope of so many others lies in research, and METAvivor-funded research is increasingly important these days. #LightUpMBC is the biggest contributor to this research and is also a way to bring us together as a community."
This sentiment is echoed by Tami Eagle Bowling, the campaign director and a veteran of the MBC community, who has been living with the disease for 11 years. For Bowling, the campaign is about more than just lights; it is about visibility. "We are here, we are living with this, and we deserve the research dollars that will allow us to live longer," she stated.
LightUpMBC Live: An Immersive Educational Experience
The centerpiece of the awareness day is the #LightUpMBC Live broadcast, scheduled for October 13 at 8 p.m. ET / 5 p.m. PT. Hosted by Tami Eagle Bowling and Broadway performer/breast cancer survivor Kara Lindsay, the event is designed to be both a celebration of life and a sobering call to action.
The program will be streamed free of charge via the METAvivor YouTube channel, Facebook Live, and the LiveOne platform. Viewers will be taken on a virtual tour of the illuminated landmarks, with patient advocates sharing their stories directly from the sites. Beyond the emotional testimonies, the stream will feature:
- Scientific Perspectives: Leading researchers will provide updates on the state of MBC drug trials and genetic research.
- Musical Performances: A star-studded lineup includes two-time Tony Award winner Victoria Clark, Tony Award nominee Dorian Harewood, actress Christina Bianco, singer-songwriter Cassandra Kubinski, and renowned voice artist Tony Daniels.
The broadcast serves as the primary fundraising event of the year for the organization. One hundred percent of the net proceeds from the campaign and the livestream are directed toward funding the next generation of metastatic breast cancer research grants.
Implications: Moving Toward a New Era of Survival
The implications of the #LightUpMBC movement are twofold. First, it addresses the "awareness gap." For years, the pink ribbon movement focused largely on the prevention of early-stage disease, inadvertently sidelining the needs of those already living with metastatic cancer. By creating a distinct, highly visible presence through the teal, green, and pink lights, the campaign forces the public to confront the existence of Stage 4 disease.
Second, the campaign shifts the narrative from "fighting" to "living." By highlighting the stories of long-term survivors like Dr. Shanahan and Tami Eagle Bowling, the movement demonstrates that with the right research, MBC patients can have years of quality time with their families.
As the landmarks ignite on October 13, they will do more than just provide a beautiful visual display. They will stand as 325 pillars of hope, reminding the global community that while Stage 4 is currently a terminal diagnosis, it does not have to remain that way. Through the continued support of donors, the relentless efforts of researchers, and the unwavering voices of patients, METAvivor is working toward a future where "Stage 4" is no longer a death sentence.
To participate in the movement, the public is encouraged to visit the illuminated landmarks, share photos on social media using the hashtags #LightUpMBC and #METAvivor, and tune into the livestream to learn how they can contribute to the search for a cure. Further details, including a map of all participating landmarks and donation links, can be found at www.lightupmbc.org.
About the Author
